Sign in
AVNS Stock Price, Chart, Stats & News
Avanos Medical, Inc.
Save
1.17B
Market cap
–
Current P/E
30.67x
Forward P/E
AVNS chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 49.77% |
Operating margin | -8.78% |
Pretax margin | -9.44% |
Net margin | -9.68% |
Effective tax rate | -2.57% |
ROA | -6.32% |
ROE | -8.56% |
D/E | 0.17x |
Interest coverage ratio | -7.90x |
AVNS valuation
P/E | – |
P/S | 0.90x |
P/B | 0.81x |
P/CF | 8.40x |
P/FCF | 14.59x |
P/OCF | 8.40x |
PEG | -0.11x |
EV multiple | -30.23x |
About
Avanos Medical, Inc. is a pioneering medical technology enterprise dedicated to furnishing device solutions across a broad international footprint, encompassing North America, Europe, the Middle East, Africa, the Asia Pacific region, and Latin America. Its comprehensive product array targets two primary areas: chronic care and non-opioid pain management. Within chronic care, the company provides digestive health offerings such as Mic-Key enteral feeding tubes, Corpak patient feeding systems, and NeoMed solutions tailored for neonatal and pediatric patients.
Similar securities
Based on sector and market capitalization
Report issue